ASHP advocates and supports the professional practice of pharmacists in hospitals, health systems, ambulatory care clinics, and other settings spanning the full spectrum of medication use. The ASHP Midyear 2022 Clinical Meeting & Exhibition convenes in Las Vegas, Nevada, at the Mandalay Bay Convention Center.
What you can expect at this year’s conference
Gathering Getting Set to Return as In-Person Event
The American Society of Health-System Pharmacists (ASHP) Midyear 2022 Clinical Meeting & Exhibition takes place from Sunday, December 4, 2022, to Thursday, December 8, 2022, in Las Vegas, Nevada. Following a couple of years of virtual Midyears brought on by COVID-19 pandemic restrictions, the meeting returns this year as an in-person assembly. Read more.
ASHP Midyear 2022 Clinical Meeting & Exhibition Schedule at a Glance
Click here Click here for an overview of key meeting events taking place during the ASHP Midyear 2022 Clinical Meeting & Exhibition, which will convene in Las Vegas, Nevada, at the Mandalay Bay Convention Center.
Sessions Hone in on Compounding Hurdles
With compounding pharmacists facing a myriad of challenges, some spurred on by lingering staffing and drug shortages, several Midyear 2022 sessions take on added importance. Selected presentations cover wide-ranging compounding topics, such as workload constraints, medication compliance in special populations, and safety concerns, including changes to USP guidance and approaches to reducing surface contamination risk. Read more.
Post Conference Wrap
ASHP Virtual Conference Connect
Employing Compounding Robots to Enhance Efficiency, Safety
In an ASHP Midyear 2022 Clinical Meeting & Exhibition Management Case Study titled “Using an IV Chemotherapy Compounding Robot Within a Comprehensive Cancer Center,” presenters from the Mayo Clinic described how one cancer care center implemented an IV chemotherapy compounding robot to enhance cancer treatment capacity, mitigate staffing shortages, and improve compounding accuracy and safety. Read more.
Planning for Seamless Sterile Compounding Renovations
In an ASHP Midyear 2022 Clinical Meeting & Exhibition Management Case Study titled “Sharp Objectives—Planning for Successful Sterile Compounding Renovations via a Centralized Dispensing Model,” Erin Stanley (right) and Amy E. Braden from University of Louisville Health described strategies for maintaining regulatory compliance during a pharmacy renovation. Read more.
Overcoming Obstacles to Parenteral Nutrition
In an ASHP Midyear 2022 Clinical Meeting & Exhibition session titled “Parenteral Nutrition—Focus on Compounding,” Kristen Kruszewski and Erinn Rowe from UNC Health offered insights into overcoming clinical- and technology-related medication safety challenges. These included strategies to solve issues posed by calcium phosphate solubility and medication-compounding component shortages, among other hurdles. Read more.
Detailing Sterile Compounding USP Chapter Changes
In a session presented during the ASHP 2022 Midyear Clinical Meeting & Exhibition, USP Compounding Expert Committee member Kevin Hansen explained changes to USP Chapter <797> governing sterile compounding. Revisions to the guidelines affect, among other areas, garbing, release inspections and testing, and multiple-dose compounded sterile products. Read more.
Paul Walker, ASHP President Elect, Galvanizes Midyear Gathering
The American Society of Health-System Pharmacists (ASHP) Midyear 2022 Clinical Meeting & Exhibition convened from Sunday, December 4, 2022, to Thursday, December 8, 2022, in Las Vegas, Nevada. Following a couple of years of virtual Midyears brought on by COVID-19 pandemic restrictions, the meeting finally returned as an in-person assembly, and Paul Walker, 2022-2023 President, got things rolling during the Opening Session. Read more.
Strahan Kickstarts Opening Session
Two-time Emmy winner, Super Bowl Champion, and Peabody Award–winning journalist Michael Strahan (right), currently cohost of ABC’s Good Morning America, highlighted the ASHP Midyear 2022 Clinical Meeting & Exhibition Opening Session on Monday, December 5. In his remarks, Mr. Strahan thanked pharmacists for "stepping up" during the pandemic when the country needed them most. Read more.
Focusing on the First FDA-Approved Liquid Oral Methotrexate
In this Pharmacist Recommendation Series video, U.S. Pharmacist Editor-in-Chief Robert Davidson interviews compounding/specialty pharmacist Amanda Ye, PharmD, RPh (above), who reviews Xatmep, the only FDA-approved oral liquid, ready-to-use methotrexate option for pharmacists. Click here to view video.
Updating Nonsterile Compounding Chapter Revisions
In an educational session presented on Sunday, December 4, at the ASHP 2022 Midyear Clinical Meeting & Exhibition, USP Compounding Expert Committee member Kevin Hansen, PharmD, MS, BCPS, BCSCP, explained recent revisions to the guidance for USP Chapter 795 governing nonsterile compounding. Changes to the current USP Chapter 795 impact personnel and training, hygiene and garbing, cleanup and sanitizing, among other aspects of nonsterile compounding. Read more .